{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:51:12Z","timestamp":1792659072272,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1378\/chest.107.2_supplement.65s","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T17:31:17Z","timestamp":1201023077000},"page":"65S-70S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"S","title":["Aerosolized Recombinant Human DNase I for the Treatment of Cystic Fibrosis"],"prefix":"10.1016","volume":"107","author":[{"given":"Steven","family":"Shak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.107.2_Supplement.65S_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(05)83478-X","article-title":"The changing epidemiology of cystic fibrosis.","volume":"122","author":"FitzSimmons","year":"1993","journal-title":"J Pediatr"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1542\/peds.24.5.739","article-title":"Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis.","volume":"24","author":"Chernick","year":"1959","journal-title":"Pediatrics"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib3","first-page":"493","article-title":"The composition of pulmonary secretions from patients with and without cystic fibrosis.","volume":"100","author":"Potter","year":"1960","journal-title":"Am J Dis Child"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib4","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.","volume":"87","author":"Shak","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"suppl","key":"10.1378\/chest.107.2_Supplement.65S_bib5","first-page":"A251","article-title":"The physical and transport properties of CF sputum after treatment with rhDNase [abstract].","volume":"9","author":"Rubin","year":"1993","journal-title":"Pediatr Pulmonol"},{"issue":"suppl","key":"10.1378\/chest.107.2_Supplement.65S_bib6","first-page":"A251","article-title":"Effects of rhDNase on cystic fibrosis sputum viscoelasticity in vitro [abstract].","volume":"9","author":"Tomkiewicz","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib7","first-page":"A671","article-title":"Dose-dependent effect of recombinant human DNase on the transport properties of cystic fibrosis respiratory mucus [abstract].","volume":"149","author":"Zahm","year":"1994","journal-title":"Am Rev Respir Dis"},{"issue":"suppl 18","key":"10.1378\/chest.107.2_Supplement.65S_bib8","first-page":"12s","article-title":"The in vitro effects of two novel drugs on the rheology of cystic fibrosis and bronchiectasis sputum.","volume":"7","author":"Shah","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib9","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jama.1992.03480140073036","article-title":"Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis: a phase I study.","volume":"267","author":"Aitken","year":"1992","journal-title":"JAMA"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM199203193261207","article-title":"A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.","volume":"326","author":"Hubbard","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1164\/ajrccm\/148.1.145","article-title":"Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.","volume":"148","author":"Ramsey","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0140-6736(93)92297-7","article-title":"Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.","volume":"342","author":"Ranasinha","year":"1993","journal-title":"Lancet"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis.","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib14","series-title":"Full prescribing information for Pulmozyme domase alfa","year":"1994"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ppul.1950170613","article-title":"Consensus conference: practical applications of Pulmozyme.","volume":"17","author":"Ramsey","year":"1994","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/ajrccm.150.2.8049828","article-title":"Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.","volume":"150","author":"Konstan","year":"1994","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1164\/ajrccm.150.1.7912987","article-title":"Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.","volume":"150","author":"Birrer","year":"1994","journal-title":"Am Rev Respir Dis"},{"issue":"suppl","key":"10.1378\/chest.107.2_Supplement.65S_bib18","first-page":"A288","article-title":"Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis [abstract].","volume":"9","author":"Kirchner","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib19","first-page":"A666","article-title":"Bronchoalveolar lavage in newly diagnosed infants with cystic fibrosis [abstract].","volume":"149","author":"Armstrong","year":"1994","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.107.2_Supplement.65S_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1055\/s-2007-1006390","article-title":"Cystic fibrosis in the year 2000.","volume":"15","author":"Rosenstein","year":"1994","journal-title":"Semin Respir Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215430272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215430272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:15:33Z","timestamp":1757920533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215430272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["S0012369215430272"],"URL":"https:\/\/doi.org\/10.1378\/chest.107.2_supplement.65s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1995,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aerosolized Recombinant Human DNase I for the Treatment of Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.107.2_Supplement.65S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}